Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for Pleural Effusion in Open Heart Surgery
NCT06681415Phase 4Completed
- Sponsor
- Pauls Stradins Clinical University Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in pleural effusion (2 arms), sponsored by Pauls Stradins Clinical University Hospital. Primary endpoints: Pleural effusion volume and Serum albumin level. Started Sep 2022; status: completed.
02
Drugs
albumin (human)
03
Conditions
pleural effusion
Beyond the preview
Go deeper on NCT06681415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06681415.